Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting

Anesthesia and Analgesia

Volumn 106, Issue 5, 2008, Pages 1407-1409

  Rosow, Carl E ^a   Haspel, Kenneth L ^b   Smith, Sarah E ^c   Grecu, Loreta ^a   Bittner, Edward A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; ONDANSETRON; ANTIEMETIC AGENT; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTANESTHESIA CARE; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; COMPARATIVE STUDY; DRUG ANTAGONISM; ELECTIVE SURGERY; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTIEMETICS; FEMALE; HALOPERIDOL; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 42449094599     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181609022     Document Type: Article

References (12)

1. Buttner M, Walder B, von Elm E, Tramer MR. Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials. Anesthesiology 2004;101:1454-63
2. Neidhart JA, Gagen M, Young D, Wilson HE. Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide. Cancer 1981;47:1439-43
3. Robbins EL, Nagel JD. Haloperidol parenterally for treatment of vomiting and nausea from gastrointestinal disorders in a group of geriatric patients: Double-blind, placebo-controlled study. J Am Geriatr Soc 1975;23:38-41
4. Tornetta FJ. Double-blind evaluation of haloperidol for antiemetic activity. Anesth Analg 1972;51:964-7
5. Barton MD, Libonati M, Cohen PJ. The use of haloperidol for treatment of postoperative nausea and vomiting - a double-blind placebo-controlled trial. Anesthesiology 1975;42:508-12
6. Eberhart LH, Mauch M, Morin AM, Wulf H, Geldner G. Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia 2002;57:1022-7
7. Byhahn C, Lotz G, Maser DA, Lischke V, Westphal K. Haloperidol or droperidol for antiemetic prophylaxis after thyroid surgery. A randomized, double-blinded clinical trial. Anesthesiology 2003; 99:A1289 [Abstract]
8. Dyrberg V. Haloperidol (Serenase®) in the prevention of postoperative nausea and vomiting. Acta Anaesthesiol Scand 1962;6:37-47
9. Aouad MT, Siddik-Sayyid SM, Taha SK, Azar MS, Nasr VG, Hakki MA, Zoorob DG, Baraka AS. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery. Eur J Anaesth 2007;24:171-8
10. Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81:238-40
11. Froemming JS, Lam YWF, Jann MW, Davis CM. Pharmacokinetics of haloperidol. Clin Pharmacokinet 1989;17:396-423
12. Fischler M, Bonnet F, Trang H, Jacob L, Levron JC, Flaisler B, Vourc'h G. The pharmacokinetics of droperidol in anesthetized patients. Anesthesiology 1986;64:486-9